Literature DB >> 1988361

Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest.

R Stein1, D M Goldenberg, M J Mattes.   

Abstract

Normal tissue reactivity on frozen sections was examined with 4 monoclonal antibodies (MAbs) that were reported previously to be negative or weakly reactive with normal tissues, and strongly reactive with some types of carcinoma. All 4 antibodies reacted strongly with certain normal epithelial cells. The antibodies tested include 2 antibodies to ovarian cancer, MOv18 and MOv19, one antibody to breast cancer, H23, and one antibody reactive with a range of carcinomas, B72.3. MOv18, MOv19 and H23 reacted with many normal glandular and ductal epithelial cells, while B72.3 reacted most strongly with secretions of the small intestine epithelium and the suprabasal squamous epithelial cells of the esophagus. Since the tissue distribution of MOv19 was very similar to that of another antibody described previously, MW207, these two antibodies were compared by competitive binding inhibition, and found to recognize the same epitope. Our data emphasize the importance of repeated, independent tests of antibody specificity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988361     DOI: 10.1002/ijc.2910470202

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.

Authors:  Y Cao; P Stosiek; G F Springer; U Karsten
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

2.  Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.

Authors:  S Adluri; F Helling; S Ogata; S Zhang; S H Itzkowitz; K O Lloyd; P O Livingston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

3.  Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.

Authors:  P Garin-Chesa; I Campbell; P E Saigo; J L Lewis; L J Old; W J Rettig
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

4.  Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

Authors:  Daniel J O'Shannessy; Gordon Yu; Robert Smale; Yao-Shi Fu; Sunil Singhal; Robert P Thiel; Elizabeth B Somers; Anil Vachani
Journal:  Oncotarget       Date:  2012-04

5.  Characterization of the human folate receptor alpha via novel antibody-based probes.

Authors:  Daniel J O'Shannessy; Elizabeth B Somers; Earl Albone; Xin Cheng; Young Chul Park; Brian E Tomkowicz; Yoshitomo Hamuro; Thomas O Kohl; Tracy M Forsyth; Robert Smale; Yao-Shi Fu; Nicholas C Nicolaides
Journal:  Oncotarget       Date:  2011-12

6.  Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4.

Authors:  Daniel J O'Shannessy; Elizabeth B Somers; Leslie M Palmer; Robert P Thiel; Pankaj Oberoi; Ryan Heath; Lisa Marcucci
Journal:  J Ovarian Res       Date:  2013-04-17       Impact factor: 4.234

7.  Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity.

Authors:  E C Abeln; W E Corver; N J Kuipers-Dijkshoorn; G J Fleuren; C J Cornelisse
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

8.  Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.

Authors:  Daniel J O'Shannessy; Elizabeth B Somers; Julia Maltzman; Robert Smale; Yao-Shi Fu
Journal:  Springerplus       Date:  2012-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.